232 related articles for article (PubMed ID: 18193246)
1. Pregnancy complicated with chronic myelogeneous leukemia (CML) successfully treated with imatinib: a case report.
Buyukbayrak EE; Ergen B; Karsidag YK; Kars B; Turan C; Argon D
Arch Gynecol Obstet; 2008 Aug; 278(2):161-3. PubMed ID: 18193246
[TBL] [Abstract][Full Text] [Related]
2. Pregnancy under treatment of imatinib and successful labor in a patient with chronic myelogenous leukemia (CML). Outcome of discontinuation of imatinib therapy after achieving a molecular remission.
Ali R; Ozkalemkaş F; Ozçelik T; Ozkocaman V; Ozan U; Kimya Y; Köksal N; Gülten T; Yakut T; Tunali A
Leuk Res; 2005 Aug; 29(8):971-3. PubMed ID: 15978950
[TBL] [Abstract][Full Text] [Related]
3. Imatinib use during pregnancy and breast feeding: a case report and review of the literature.
Ali R; Ozkalemkas F; Kimya Y; Koksal N; Ozkocaman V; Gulten T; Yorulmaz H; Tunali A
Arch Gynecol Obstet; 2009 Aug; 280(2):169-75. PubMed ID: 19083009
[TBL] [Abstract][Full Text] [Related]
4. Persistence of molecular remission throughout pregnancy in CML after imatinib.
Sorà F; De Matteis S; Bajer J; D'alò F; Leone G; Sica S
Leuk Res; 2009 Jun; 33(6):e6-7. PubMed ID: 18937976
[No Abstract] [Full Text] [Related]
5. Twin pregnancy in a patient of chronic myeloid leukemia on imatinib therapy.
Meera V; Jijina F; Shrikande M; Madkaikar M; Ghosh K
Leuk Res; 2008 Oct; 32(10):1620-2. PubMed ID: 18420270
[TBL] [Abstract][Full Text] [Related]
6. Pregnancy among patients with chronic myeloid leukemia treated with imatinib.
Ault P; Kantarjian H; O'Brien S; Faderl S; Beran M; Rios MB; Koller C; Giles F; Keating M; Talpaz M; Cortes J
J Clin Oncol; 2006 Mar; 24(7):1204-8. PubMed ID: 16446320
[TBL] [Abstract][Full Text] [Related]
7. Acute myeloid leukemia developing during imatinib mesylate therapy for chronic myeloid leukemia in the absence of new cytogenetic abnormalities.
Pawarode A; Sait SN; Nganga A; Coignet LJ; Barcos M; Baer MR
Leuk Res; 2007 Nov; 31(11):1589-92. PubMed ID: 17391756
[TBL] [Abstract][Full Text] [Related]
8. [Clinical analysis about the management and the perinatal outcomes of pregnancy with chronic myeloid leukemia].
Wang DP; Liang MY; Zhang XH; Wang SM
Zhonghua Fu Chan Ke Za Zhi; 2010 Oct; 45(10):735-9. PubMed ID: 21176552
[TBL] [Abstract][Full Text] [Related]
9. First and second line imatinib treatment in chronic myelogenous leukemia patients expressing rare e1a2 or e19a2 BCR-ABL transcripts.
Andrikovics H; Nahajevszky S; Szilvási A; Bors A; Adám E; Kozma A; Kajtár B; Barta A; Poros A; Tordai A
Hematol Oncol; 2007 Sep; 25(3):143-7. PubMed ID: 17530620
[TBL] [Abstract][Full Text] [Related]
10. Chronic myeloid leukemia with pregnancy: Successful management of pregnancy and delivery with hydroxyurea and imatinib continued till delivery.
Yadav U; Solanki SL; Yadav R
J Cancer Res Ther; 2013; 9(3):484-6. PubMed ID: 24125987
[TBL] [Abstract][Full Text] [Related]
11. Fatherhood during imatinib.
Shash E; Bassi S; Cocorocchio E; Colpi GM; Cinieri S; Peccatori FA
Acta Oncol; 2011 Jun; 50(5):734-5. PubMed ID: 21517714
[No Abstract] [Full Text] [Related]
12. Molecular response to imatinib in patient with Ph negative p190 BCR-ABL transcript positive chronic myeloid leukemia with cyclic leukocytosis.
Radojkovic M; Ristic S; Pavlovic S; Colovic M
Leuk Res; 2009 Jun; 33(6):e10-2. PubMed ID: 19091403
[TBL] [Abstract][Full Text] [Related]
13. Introduction: CML in the imatinib era.
Hehlmann R
Best Pract Res Clin Haematol; 2009 Sep; 22(3):283-4. PubMed ID: 19959079
[No Abstract] [Full Text] [Related]
14. [Emergence and decrement of Ph-negative clone with trisomy 8 in CML during imatinib therapy].
Kimura F; Kobayashi S; Ogura K; Kobayashi A; Torikai H; Ikeda T; Sato K; Motoyoshi K
Rinsho Ketsueki; 2004 Sep; 45(9):1058-60. PubMed ID: 15510836
[TBL] [Abstract][Full Text] [Related]
15. Investigational strategies in chronic myelogenous leukemia.
Cortes JE; O'Brien SM; Giles F; Alvarez RH; Talpaz M; Kantarjian HM
Hematol Oncol Clin North Am; 2004 Jun; 18(3):619-39, ix. PubMed ID: 15271396
[TBL] [Abstract][Full Text] [Related]
16. Treatment options in imatinib-resistant chronic myelogenous leukemia.
Marshall HM; Hammond JM
Ann Pharmacother; 2008 Feb; 42(2):259-64. PubMed ID: 18212257
[TBL] [Abstract][Full Text] [Related]
17. Membranoproliferative glomerulonephritis secondary to chronic myeloid leukemia.
Subramanian M; Kilara N; Manjunath R; Mysorekar V
Saudi J Kidney Dis Transpl; 2010 Jul; 21(4):738-41. PubMed ID: 20587884
[TBL] [Abstract][Full Text] [Related]
18. Hypolipemiant besides antileukemic effect of imatinib mesylate.
Gologan R; Constantinescu G; Georgescu D; Ostroveanu D; Vasilache D; Dobrea C; Iancu D; Popov V
Leuk Res; 2009 Sep; 33(9):1285-7. PubMed ID: 19327828
[TBL] [Abstract][Full Text] [Related]
19. Promyelocytic crisis of chronic myelogenous leukaemia during imatinib mesylate treatment.
Oku E; Imamura R; Nagata S; Takata Y; Seki R; Otsubo K; Hashiguchi M; Osaki K; Yakushiji K; Yoshimoto K; Ogata H; Sata M; Okamura T
Acta Haematol; 2007; 117(4):191-6. PubMed ID: 17170522
[TBL] [Abstract][Full Text] [Related]
20. Male patients with chronic myeloid leukemia treated with imatinib involved in healthy pregnancies: report of five cases.
Breccia M; Cannella L; Montefusco E; Frustaci A; Pacilli M; Alimena G
Leuk Res; 2008 Mar; 32(3):519-20. PubMed ID: 17804066
[No Abstract] [Full Text] [Related]
[Next] [New Search]